cbdMD Corp (YCBD): Total Asset Value of Company

Graphic logo of cbdmd.com (YCBD)

The share price visualized below reflects the dynamics of cbdMD, Inc. (YCBD) total assets, which currently stand at 12.29. The business is based on the efficient distribution of CBD products through omnichannel networks and automated warehouses. The company's resilience is bolstered by an impeccable brand image and consumer recognition of product quality, allowing the enterprise to remain a benchmark in its market segment.

cbdMD (YCBD) Company Total Assets: for the period 07/04/2022 - 10/29/2026

Comprehensive metric breakdowns and analytics for cbdmd.com (YCBD)

- price and consensus price forecast:
Share Price cbdMD|YCBD - Price Target Chart
- market capitalization data:
Market Valuation cbdMD, Inc.|YCBD - Enterprise Value
- book capitalization data:
Accounting Value of a Share cbdMD|YCBD - Book Capitalization|Market Capitalization to Book Value Ratio cbdmd.com|YCBD - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio cbdMD, Inc.|YCBD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio cbdMD|YCBD - Company Aggregate Debts|Debts to Book Capitalization cbdMD, Inc.|YCBD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings cbdMD
Fundamental valuation:YCBD, cbdMD Corp
Finished products of cbdMD Inc.

To minimize risks during long-term investing, it is critical to account for resource volatility, which, combined with high customer brand loyalty to cbdMD, Inc. (YCBD), allows for an assessment of capital management efficiency through an analysis of all company resources, calculated reversely via ROA as the sum of liabilities and equity to determine the fundamental value of the business.

Competitors of cbdMD, Inc. (YCBD)

HLN (haleon.com) - Total Business Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value oramed.com (ORMP)|Entera Bio - Company Total Assets|Cumulative Company Assets MindWalk Holdings, Inc. HYFT|ABVC - Company Total Assets|CPIX - Aggregate Company Assets|Company Total Assets Quantum BioPharma Ltd|FGEN (fibrogen.com) - Total Business Assets|Aggregate Company Assets TELO|Cumulative Company Assets Rani Therapeutics Inc|Company Total Assets Synergy CHC Corp SNYR|Total Business Assets rallybio.com RLYB|Cumulative Company Assets Lexaria Bioscience Corp.|Aggregate Asset Value pulmatrix.com PULM|Company Total Assets PTHL (Pheton)|APM: Company Total Asset Base|Aggregate Company Assets Lyra Therapeutics, Inc|Impact BioMedical, Inc. (IBO) - Total Business Assets|Company Total Assets TNFA|Cumulative Company Assets painreform.com (PRFX)|CYTO (Altamira Therapeutics) - Cumulative Company Assets|Company Total Asset Base Lipella Pharmaceuticals Inc LIPO|OPTN: Cumulative Company Assets|Company Assets Pieris Pharma PIRS|PROC: Company Total Assets|PTPI - Cumulative Company Assets|Qilian International Holding (QLI) - Company Total Assets|Acelyrin Inc. (SLRN) - Aggregate Company Assets|Company Total Assets TFF Pharma (TFFP)